These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32640024)

  • 1. An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
    Deelen JWT; Rottier WC; Giron Ortega JA; Rodriguez-Baño J; Harbarth S; Tacconelli E; Jacobsson G; Zahar JR; van Werkhoven CH; Bonten MJM;
    Clin Infect Dis; 2021 Dec; 73(11):e4475-e4483. PubMed ID: 32640024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study.
    Aiken AM; Rehman AM; de Kraker MEA; Madrid L; Kebede M; Labi AK; Obeng-Nkrumah N; Nyamwaya B; Kagucia E; Cocker D; Kawaza K; Lester R; Iregbu KC; Medugu N; Nwajiobi-Princewill PI; Dramowski A; Sonda T; Hemed A; Fwoloshi S; Ojok D; Scott JAG; Whitelaw A;
    Lancet Infect Dis; 2023 Nov; 23(11):1280-1290. PubMed ID: 37454672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
    Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
    de la Court JR; Heijmans J; Huynh J; Sieswerda E; de Jonge NA; van Dijk K; Sigaloff KCE; Schade RP
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):160. PubMed ID: 36529742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital.
    Dramowski A; Aiken AM; Rehman AM; Snyman Y; Reuter S; Grundmann H; Scott JAG; de Kraker MEA; Whitelaw A
    J Glob Antimicrob Resist; 2022 Jun; 29():176-184. PubMed ID: 35283332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
    Maillard A; Delory T; Bernier J; Villa A; Chaibi K; Escaut L; Contejean A; Bercot B; Robert J; El Alaoui F; Tankovic J; Poupet H; Cuzon G; Lafaurie M; Surgers L; Joseph A; Paccoud O; Molina JM; Bleibtreu A;
    Int J Antimicrob Agents; 2023 Jul; 62(1):106809. PubMed ID: 37028731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hospital environment versus carriage: transmission pathways for third-generation cephalosporin-resistant bacteria in blood in neonates in a low-resource country healthcare setting.
    Kovacs D; Silago V; Msanga DR; Mshana SE; Seni J; Oravcova K; Matthews L
    Sci Rep; 2022 May; 12(1):8347. PubMed ID: 35589773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of empirical antibiotic prescription for bloodstream infections in an emergency department from 2006 to 2018: impact of the spread of ESBL-producing Enterobacterales.
    Clemenceau M; Ahmed-Elie S; Vilfaillot A; Chocron R; Compain F; Lebeaux D; Grohs P
    Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):71-77. PubMed ID: 34553311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, Fiji.
    Loftus MJ; Young-Sharma TEMW; Lee SJ; Wati S; Badoordeen GZ; Blakeway LV; Byers SMH; Cheng AC; Cooper BS; Cottingham H; Jenney AWJ; Hawkey J; Macesic N; Naidu R; Prasad A; Prasad V; Tudravu L; Vakatawa T; van Gorp E; Wisniewski JA; Rafai E; Peleg AY; Stewardson AJ
    J Glob Antimicrob Resist; 2022 Sep; 30():286-293. PubMed ID: 35738385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan.
    Lin WP; Huang YS; Wang JT; Chen YC; Chang SC
    BMC Infect Dis; 2019 Mar; 19(1):245. PubMed ID: 30866828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
    Lester R; Musicha P; van Ginneken N; Dramowski A; Hamer DH; Garner P; Feasey NA
    J Antimicrob Chemother; 2020 Mar; 75(3):492-507. PubMed ID: 31742611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.
    Mehl A; Åsvold BO; Kümmel A; Lydersen S; Paulsen J; Haugan I; Solligård E; Damås JK; Harthug S; Edna TH
    BMC Infect Dis; 2017 Feb; 17(1):116. PubMed ID: 28148226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the burden of antimicrobial resistance in Malawi: protocol for a prospective observational study of the morbidity, mortality and economic cost of third-generation cephalosporin resistant bloodstream infection.
    Lester R; Maheswaran H; Jewell CP; Lalloo DG; Feasey NA
    Wellcome Open Res; 2020; 5():29. PubMed ID: 32566760
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
    Courpon-Claudinon A; Lefort A; Panhard X; Clermont O; Dornic Q; Fantin B; Mentré F; Wolff M; Denamur E; Branger C;
    Clin Microbiol Infect; 2011 Apr; 17(4):557-65. PubMed ID: 20649802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual and population level costs and health-related quality of life outcomes of third-generation cephalosporin resistant bloodstream infection in Blantyre, Malawi.
    Lester R; Mango J; Mallewa J; Jewell CP; Lalloo DA; Feasey NA; Maheswaran H
    PLOS Glob Public Health; 2023; 3(6):e0001589. PubMed ID: 37347746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.
    Dramowski A; Ong'ayo G; Rehman AM; Whitelaw A; Labi AK; Obeng-Nkrumah N; Ndir A; Magwenzi MT; Onyedibe K; Wolkewitz M; de Kraker MEA; Scott JAG; Aiken AM;
    JAC Antimicrob Resist; 2021 Mar; 3(1):dlaa130. PubMed ID: 34223079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study.
    de la Court JR; Woudt SHS; Schoffelen AF; Heijmans J; de Jonge NA; van der Bruggen T; Bomers MK; Lambregts MMC; Schade RP; Sigaloff KCE;
    Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):54. PubMed ID: 36443758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and Risk Factors for Third-Generation Cephalosporin-Resistant
    Cheng J; Liu Y; Li S; Pu K; Yang L; Tan L
    Infect Drug Resist; 2024; 17():543-550. PubMed ID: 38352624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.